Yes, scopolamine transdermal patches can cause eye problems, most notably blurred vision, dilated pupils (mydriasis), and potentially acute angle-closure glaucoma in susceptible patients.
The FDA drug label explicitly warns that scopolamine patches cause blurred vision and pupil dilation, especially when the medication contacts the eyes, and patients with open-angle glaucoma must remove the patch immediately if they develop symptoms of acute angle-closure glaucoma 1.
Primary Eye Problems from Scopolamine Patches
Blurred Vision and Mydriasis (Most Common)
- Blurred vision is listed as one of the most common side effects of scopolamine transdermal systems 1
- Pupil dilation (mydriasis) occurs particularly when the patch or contaminated fingers contact the eyes 1
- The mechanism is anticholinergic blockade of muscarinic receptors in the eye 2
Acute Angle-Closure Glaucoma (Most Serious)
Patients with open-angle glaucoma face specific risk: The FDA label mandates that these patients remove the patch immediately and contact their healthcare provider if they experience:
- Pain and reddening of the eyes
- Dilated pupils
- Blurred vision and/or seeing halos around lights 1
This represents a potentially sight-threatening emergency requiring immediate intervention.
Anisocoria (Unilateral Pupil Dilation)
Multiple case reports document unilateral mydriasis (one dilated pupil) from inadvertent scopolamine patch contamination 3, 4, 5, 6. This occurs when:
- Patients touch the patch and then touch one eye
- The patch is positioned such that medication transfers to one eye
- This can mimic serious neurological conditions (e.g., "blown pupil" from intracranial pathology), leading to unnecessary extensive workup 5
Clinical presentation: The affected pupil typically measures 4-5mm while the unaffected pupil remains 2-3mm 4. Response to pilocarpine testing is inconsistent—some cases show no constriction (typical anticholinergic effect), while others show initial constriction followed by re-dilation 3, 4.
Resolution: Anisocoria from scopolamine contamination resolves spontaneously over 2-4 days without intervention 4.
Additional Anticholinergic Eye Effects
Clinical guidelines note that all anticholinergics including scopolamine can cause 2:
- Blurring of vision
- Dilated pupils
- Dry eyes (as part of general anticholinergic effects)
Critical Prevention Measures
The FDA label provides specific instructions to prevent eye contamination 1:
- Wash hands thoroughly with soap and water immediately after handling the patch
- Do not touch the patch while wearing it
- Wash hands AND the application site with soap and water after patch removal
- Avoid touching eyes after handling the patch
Clinical Context from Guidelines
While guidelines discuss scopolamine primarily for vertigo management 2 and secretion control in palliative care 7, 8, they consistently note the anticholinergic side effect profile including ocular effects. The 2020 Ménière's disease guideline specifically states that scopolamine and other anticholinergics "can cause blurring of vision, dry mouth, dilated pupils, urinary retention, and sedation" 2.
Common Pitfalls to Avoid
Mistaking scopolamine-induced anisocoria for neurological emergency: Always obtain detailed medication history including patch use before pursuing extensive neurological workup for isolated unilateral mydriasis 5
Assuming bilateral effects only: While systemic anticholinergic toxicity typically causes bilateral mydriasis, unilateral effects from contamination are well-documented 3, 4, 5, 6
Over-relying on pilocarpine testing: The response to pilocarpine in scopolamine-induced mydriasis is inconsistent and cannot definitively rule out pharmacological causes 3, 4
Inadequate patient education: Many patients are unaware that touching the patch and then their eyes can cause significant ocular effects 1
Bottom Line
Scopolamine patches reliably cause blurred vision and can cause pupil dilation, particularly with eye contamination. Patients with glaucoma require specific warnings about acute angle-closure risk. Proper hand hygiene after patch handling is essential to prevent ocular complications.